FDA.reportPublic FDA data

ETHYL BUTYRATE

Substance profile for UNII UFD2LZ005D, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ETHYL BUTYRATE
Structure render from PubChem CID 7762

Substance Identity#

UNII
UFD2LZ005D
Preferred term
ETHYL BUTYRATE
Registry number
105-54-4
EC number
203-306-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H12O2
Chemical structure for ETHYL BUTYRATE
Structure render from PubChem CID 7762

Chemical And Database Identifiers#

InChIKey
OBNCKNCVKJNDBV-UHFFFAOYSA-N
SMILES
CCCC(=O)OCC
RxCUI
1314356
PubChem
7762
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound7762https://pubchem.ncbi.nlm.nih.gov/compound/7762
PubChem InChIKey SearchOBNCKNCVKJNDBV-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=OBNCKNCVKJNDBV-UHFFFAOYSA-N
RxNorm1314356https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1314356
FDA Substance Registration SystemUFD2LZ005Dhttps://precision.fda.gov/uniisearch/srs/unii/UFD2LZ005D
European Community number203-306-4https://commonchemistry.cas.org/results?q=203-306-4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ETHYL BUTYRATEINACTIVE INGREDIENTUFD2LZ005DThese highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 19951
ETHYL BUTYRATEINACTIVE INGREDIENTUFD2LZ005DEVERYDAY FACE AND BODY BROAD SPECTRUM SPF 30 SUPERGOOP (AVOBENZONE, OCTINOXATE, OCTISALATE, OCTOCRYLENE) LOTION [TAYLOR JAMES, LTD.]7
ETHYL BUTYRATEINACTIVE INGREDIENTUFD2LZ005DSAVE FACE AM MOISTURIZER BROAD SPECTRUM SPF 35 SUPERGOOP (AVOBENZONE,OCTINOXATE, OCTISALATE,OCTOCRYLENE) LOTION [TAYLOR JAMES, LTD.]6